LTHUQ yields 20000000.00% · MRK yields 2.76%● Live data
📍 LTHUQ pulled ahead of the other in Year 1
Combined, LTHUQ + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LTHUQ + MRK for your $10,000?
Lithium Technology Corporation engages in the design, manufacture, marketing, and delivery of rechargeable energy storage solutions. The company designs and builds large format cylindrical lithium-ion (Li-ion) rechargeable cells, as well as Li-ion rechargeable batteries with battery management systems for use in transportation, military/national security, and stationary power markets. Its product portfolio includes large format high power cells ranging from 7.5 to 45 Ah with high discharge capabilities designed for HEV and military applications; high energy cells ranging from 10 to 485 Ah for various applications, such as back-up power and remote standby installations; large batteries up to 600V and capacity of more than 1.2 MWh; and standard cells that are assembled into custom large batteries complete with electronics to manage the batteries. The company markets its products to industrial, retail, and government customers, as well as to scientific research facilities and national defense agencies primarily in the United States, United Kingdom, and Germany. Lithium Technology Corporation is headquartered in Fairfax, Virginia. On December 5, 2014, Lithium Technology Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Virginia.On June 12, 2015, the voluntary petition of Lithium Technology Corp. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on December 5, 2014.
Full LTHUQ Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.